+($/7+(&2120,&6*(1(5$/,668(6

&KDSWHU

+($/7+(&2120,&6*(1(5$/,668(6

7KH(FRQRPLFVRI+HDOWKDQG+HDOWK&DUH
2YHU WKH SDVW GHFDGHV WKH DELOLW\ WR SURYLGH WUHDWPHQW IRU DQ LQFUHDVLQJO\ ZLGH UDQJH RI GLVHDVHV
KDV LQFUHDVHG H[SRQHQWLDOO\ ZLWK WKH LQWURGXFWLRQ RI QHZ WHFKQRORJLHV 'HPDQG IRU FDUH DOVR KDV
LQFUHDVHGSDUWO\LQUHVSRQVHWRWKLVEXWDOVRIRURWKHUUHDVRQV7KHUHVXOWLQJULVHLQKHDOWKFDUHFRVWV
KDVSXWFRQVLGHUDEOHVWUDLQRQ¿QLWHUHVRXUFHVDVLWXDWLRQWKDWKDVZRUVHQHGLQWKHIDFHRIWKHFXUUHQW
global economic slowdown.

(FRQRPLF LVVXHV LQ KHDOWK FDUH DUH QRZ GLVFXVVHG ZLGHO\²LQ SXEOLF SROLF\ IRUXPV WKH PHGLFDO DQG
VFLHQWL¿F OLWHUDWXUH DQG WKH OD\ SUHVV 7KLV LV D V\PSWRP RI DQ LPSRUWDQW FKDQJH LQ KHDOWK FDUH
PDUNHWV $WWHQWLRQ KDV VKLIWHG IURP WKH ³SDVVLYH´ IXQGLQJ DQG DGPLQLVWUDWLRQ RI V\VWHPV WR DFWLYH
FRQFHUQDERXWWKHFRVWRIFDUHDQGWKHKHDOWKRXWFRPHVDFKLHYHG7KHKHDOWKHFRQRPLFWKLQNLQJWKDW
QRZSHUPHDWHVKHDOWKSROLF\DQGKHDOWKFDUHV\VWHPVLVUDLVLQJTXHVWLRQVVXFKDV+RZPXFKVKRXOG
ZHVSHQGRQKHDOWKFDUHDQGKRZGRZHHQVXUHLWLVVSHQWHI¿FLHQWO\"+RZDQGZKHQVKRXOGZHDVVHVV
WKHRXWFRPHRIXVLQJKHDOWKWHFKQRORJLHVLQFOLQLFDOSUDFWLFHWRHQVXUHUHVRXUFHVDUHXVHGHI¿FLHQWO\"

%R['H¿QLWLRQRIKHDOWKHFRQRPLFV

+HDOWKHFRQRPLFVLVWKHDSSOLFDWLRQRIWKHWKHRULHVWRROVDQGFRQFHSWVRIWKHGLVFLSOLQHRIHFRQRPLFVWRWKHWRSLFV
RIKHDOWKDQGKHDOWKFDUH

(FRQRPLFVDVDVFLHQFHLVFRQFHUQHGZLWKWKHDOORFDWLRQRIVFDUFHUHVRXUFHVKHDOWKHFRQRPLFVLVFRQFHUQHGZLWK
WKHDOORFDWLRQRIVFDUFHUHVRXUFHVWRLPSURYHKHDOWK7KLVLQFOXGHVERWKUHVRXUFHDOORFDWLRQZLWKLQWKHHFRQRP\WR
WKHKHDOWKFDUHV\VWHPDQGZLWKLQWKHKHDOWKFDUHV\VWHPWRGLIIHUHQWDFWLYLWLHVDQGLQGLYLGXDOV

$UDQJHRIDSSURDFKHVWRHFRQRPLFHYDOXDWLRQKDVEHHQGHYHORSHGWRKHOSDGGUHVVWKHVHLPSRUWDQW
TXHVWLRQVRIHI¿FLHQF\7KLVJXLGHSURYLGHVDQLQWURGXFWLRQWRWKHP7KH¿UVWFKDSWHUUHYLHZVFRQWH[WXDO
EDFNJURXQGLOOXVWUDWLQJWKHLQFUHDVHGOHYHORILQWHUHVWLQWKHXVHRIHFRQRPLFVE\SROLF\PDNHUVSD\HUV
DQGKHDOWKFDUHSURYLGHUV&KDSWHULQWURGXFHVWKHYDULRXVW\SHVRIHFRQRPLFHYDOXDWLRQDQGGLVFXVVHV
KRZWKH\DSSURDFKWKHWZRFRPSRQHQWVRIHFRQRPLFHYDOXDWLRQZKDWHIIHFWDWUHDWPHQWKDVRQKHDOWK
DQGZKDWLWFRVWV7KHFKDOOHQJHVDUHLOOXVWUDWHGZLWKH[DPSOHVRIFRVWRILOOQHVVVWXGLHVZKLFKVHHN
WRTXDQWLI\WKHDJJUHJDWHFRVWVRIDGLVHDVHDQGLWVWUHDWPHQW&KDSWHUH[SORUHVWKHPHWKRGVRI
HFRQRPLFHYDOXDWLRQLQJUHDWHUGHWDLOIRFXVLQJSDUWLFXODUO\RQWKHXVHRIPRGHOOLQJWHFKQLTXHVWKDW
V\QWKHVLVHGDWDIURPDUDQJHRIVRXUFHV7KHFKDSWHULOOXVWUDWHVWKHVHWHFKQLTXHVXVLQJDQXPEHURI

%R['H¿QLWLRQRIKHDOWKWHFKQRORJ\DVVHVVPHQW

+HDOWKWHFKQRORJ\DVVHVVPHQW+7$LVDPXOWLGLVFLSOLQDU\SURFHVVWKDWVXPPDULVHVLQIRUPDWLRQDERXWWKHPHGLFDO

VRFLDOHFRQRPLFDQGHWKLFDOLVVXHVUHODWHGWRWKHXVHRIDKHDOWKWHFKQRORJ\WKURXJKRXWLWVOLIHVSDQLQDV\VWHPDWLF
transparent, unbiased and robust manner.

7KHDLPRI+7$LVWRLQIRUPWKHIRUPXODWLRQRIVDIHDQGHIIHFWLYHKHDOWKSROLFLHVWKDWDUHSDWLHQWIRFXVHGDQGVHHN
WRDFKLHYHYDOXHIRUPRQH\

1
 +($/7+(&2120,&6*(1(5$/,668(6

H[DPSOHVSULPDULO\IURPHYDOXDWLRQVRIGUXJV,PSRUWDQWDVSHFWVRIHDFKPHWKRGRORJ\DUHH[SODLQHG
DQGSDUWLFXODUFKDOOHQJHVLGHQWL¿HG&KDSWHUGLVFXVVHVPHWKRGRORJLFDOJXLGHOLQHVIRUWKHFRQGXFWRI
WKHHFRQRPLFHYDOXDWLRQVWKDWDUHUHTXLUHGRUVXJJHVWHGLQVHYHUDOFRXQWULHV&KDSWHUFRQFOXGHV

&KDOOHQJHVLQKHDOWKFDUHWKHFRQWH[W

7RWDOKHDOWKFDUHVSHQGLQJDVDSURSRUWLRQRIJURVVGRPHVWLFSURGXFW*'3KDVVWHDGLO\LQFUHDVHGLQ

DOO2(&'FRXQWULHVDOEHLWVWDUWLQJIURPGLIIHUHQWOHYHOV6SHQGLQJLQWKH(XURSHDQ8QLRQZDVEHWZHHQ
DQGRI*'3LQWRLQ:HVWHUQ(XURSHWRLQ&HQWUDO(DVWHUQ
(XURSH,QWKH86LWUHDFKHGRYHURI*'3VHH7DEOH

7DEOH+HDOWKFDUHH[SHQGLWXUHVDVSHUFHQWDJHRI*'3
&RXQWU\RU5HJLRQ     

2(&'DYHUDJH 5.8% 7.3% 8.7% 8.4% 9.3%

86 6.9% 8.7% 11.9% 13.2% 17.7%

-DSDQ 4.6% 6.5% 6.1% 7.7% 9.6%

:HVWHUQ(XURSH 4.7% 6.7% 7.1% 8.4% 9.5%

&HQWUDO(DVWHUQ(XURSH NA NA NA 6.1% 7.9%

/DWLQ$PHULFD NA NA NA NA 7.0%
6RXUFH2(&':+2

1XPHURXVLQWHUGHSHQGHQWIDFWRUVFRQWULEXWHWRLQFUHDVHGKHDOWKFDUHFRVWVDVLQGLFDWHGLQ)LJXUH
,QWKHLQGXVWULDOLVHGZRUOGWKHHOGHUO\SRSXODWLRQRIWHQLVVLQJOHGRXWIRUFRQFHUQDVLWFRQVXPHVD
VXEVWDQWLDODQGLQFUHDVLQJVKDUHRIKHDOWKFDUHUHVRXUFHV+HDOWKFDUHH[SHQGLWXUHVKDYHULVHQOHVV
EHFDXVH RI GHPRJUDSKLF FKDQJH KRZHYHU WKDQ EHFDXVH RI WKH DYDLODELOLW\ RI D JUHDWHU QXPEHU RI
WUHDWPHQWRSWLRQVDQGFRQWLQXRXVLPSURYHPHQWLQWKHTXDOLW\DQGLQWHQVLW\RIFDUH0RUHFDQEHGRQH
so more is done.

)LJXUH0DMRUFRQWULEXWRUVWRWKHJURZWKRIKHDOWKFDUHFRVWV

Demographics Information
(Ageing population) (Educated consumer)

Standard of living Relative price effects

(Quality of life expectations) Costs (Skill intensity)

Lifestyle Innovation
(Abuse) (Technology)
Structure
(Incentives)

&RQFHUQVDERXWWKH¿QDQFLQJRIKHDOWKFDUHDUHKLJKRQHYHU\JRYHUQPHQW¶VDJHQGDSDUWLFXODUO\LQ
FRXQWULHVZKHUHKHDOWKFDUHLVSUHGRPLQDQWO\IXQGHGZLWKSXEOLFPRQH\YLDWD[HVVRFLDOLQVXUDQFHRUD
FRPELQDWLRQRIWKHWZRVHH7DEOH$PRQJWKH2(&'FRXQWULHVWKH86LVDQH[FHSWLRQZLWKPRVW
KHDOWKFDUHEHLQJ¿QDQFHGE\SULYDWHLQVXUDQFHDOWKRXJKSXEOLF¿QDQFLQJLVLQFUHDVLQJVWHDGLO\7KH
SULYDWHSRUWLRQRIWKHPDUNHWLQ/DWLQ$PHULFDQFRXQWULHVLVVXEVWDQWLDODQGJURZLQJ

Governments around the world, and particularly in Europe, have attempted to contain costs using a
YDULHW\RIPHDVXUHVDLPHGDWERWKWKHGHPDQGIRUDQGWKHVXSSO\RIKHDOWKFDUH)LJXUHVKRZV
WKRVH WKDW KDYH EHHQ DLPHG DW WKH SUHVFULSWLRQ SKDUPDFHXWLFDO PDUNHW 7KHVH PHDVXUHV KRZHYHU
KDYHEHHQOHVVVXFFHVVIXOWKDQKRSHGSDUWO\EHFDXVHJURZWKLQVSHQGLQJLVGULYHQSULPDULO\E\WKH
DYDLODELOLW\RIQHZDQGLPSURYHGWHFKQRORJ\WRZKLFKFRVWFRQWDLQPHQWPHDVXUHVDUHOHVVHDVLO\DSSOLHG

2
 +($/7+(&2120,&6*(1(5$/,668(6

7DEOH3XEOLFKHDOWKH[SHQGLWXUHVDVSHUFHQWRIWRWDOKHDOWKH[SHQGLWXUHV
&RXQWU\RUUHJLRQ     

2(&'DYHUDJH 73% 73% 73% 72% 72%

86 36% 41% 39% 43% 48%

-DSDQ 70% 71% 78% 81% 81%*

:HVWHUQ(XURSH 76% 76% 77% 76% 76%

&HQWUDO(DVWHUQ(XURSH NA NA NA 75% 72%

/DWLQ$PHULFD NA NA NA NA 52%

'DWDIRU
6RXUFH2(&':+2

)LJXUH([DPSOHVRIPHDVXUHVIRUFRQWDLQLQJVSHQGLQJRQSUHVFULSWLRQGUXJVLQ(XURSH

3ULFLQJ &OXVWHULQJVDPHSULFHIRUVLPLODUWUHDWPHQWV

3ULFHFXWVSULFHIUHH]HV
5HIHUHQFHSULFLQJ

/LVWLQJ 'HOLVWLQJUHPRYDOIURPHOLJLELOLW\IRUUHLPEXUVHPHQW

3RVLWLYHRUQHJDWLYHOLVWVRISURGXFWVHOLJLEOHIRUFRYHUDJH

6KDSLQJXVH *UHDWHUXVHRIJHQHULFVDQGRUFRQWURORIJHQHULFSULFHV
Increased patient co-payment
3UHVFULELQJEXGJHWVDQGRUJXLGHOLQHVIRUGRFWRUV

3XUFKDVLQJ Tendering
Volume contracts

,QGLUHFWFRVWFRQWURO 3UR¿WOLPLWVIRUPDQXIDFWXUHUV
3URPRWLRQDOEXGJHWOLPLWVIRUPDQXIDFWXUHUV
5HGXFWLRQVLQZKROHVDOHDQGUHWDLOSKDUPDF\PDUJLQV

7KH ¿QDQFLDO FULVLV WKDW EHJDQ LQ WKH ODWH V KDV H[DFHUEDWHG WKH VLWXDWLRQ E\ PDNLQJ IXUWKHU
LQFUHDVHV LQ SXEOLF VSHQGLQJ RQ KHDOWK FDUH PRUH GLI¿FXOW 'LVFXVVLRQV DQG GHFLVLRQV DERXW SULFHV
DQGSXUFKDVLQJDVDUHVXOWDUHQRZWDNLQJSODFHLQDQHQYLURQPHQWFKDUDFWHULVHGPRUHE\FRQFHUQ
DERXWFRVWDQGYDOXHWKDQDERXWGHPDQGIRULQQRYDWLRQ+HDOWKFDUHGHFLVLRQPDNHUVHYHU\ZKHUHDUH
IRFXVLQJPRUHQDUURZO\RQHI¿FLHQF\DQGZLWKLQWLJKWHUEXGJHWV1HZPRUHH[SHQVLYHWKHUDSLHVPXVW
FDUU\DFOHDUDGGLWLRQDOKHDOWKEHQH¿WWREHGHHPHGZRUWK\RIDQDGGLWLRQDOH[SHQGLWXUH'HFLVLRQV
PDNHUVWKHQZLOOLQFUHDVLQJO\UHTXLUHWKDWLQQRYDWLYHWKHUDSLHV²PHGLFLQHVDQGRWKHULQWHUYHQWLRQV²
EH DVVHVVHG IRU UHODWLYH HIIHFWLYHQHVV DQG FRVWHIIHFWLYHQHVV UDWKHU WKDQ RQO\ HI¿FDF\ DQG VDIHW\
VHH)LJXUH

)LJXUH$VVHVVPHQWFULWHULDIRUQHZWKHUDSLHV

6DIHW\ 'RHVLWKDYHVLGHHIIHFWVDQGDUHWKHVHDFFHSWDEOHDQGPDQDJHDEOH"

(I¿FDF\ 'RHVLWZRUNLQDFRQWUROOHGHQYLURQPHQWFOLQLFDOWULDOV"

5HODWLYHHI¿FDF\  RZZHOOGRHVLWZRUNLQDFRQWUROOHGHQYLURQPHQWFRPSDUHGWRRQHRUPRUH
+
DOWHUQDWLYHVVWDQGDUGWUHDWPHQW"

(IIHFWLYHQHVV 'RHVLWZRUNLQQRUPDOFOLQLFDOSUDFWLFH"

5HODWLYHHIIHFWLYHQHVV +RZZHOOGRHVLWZRUNLQQRUPDOFOLQLFDOSUDFWLFHFRPSDUHGWRRWKHUDOWHUQDWLYHV
VWDQGDUGWUHDWPHQW"

&RVWHIIHFWLYHQHVV , VLWDQHI¿FLHQWXVHRIUHVRXUFHVLHLVDQDGGLWLRQDOEHQH¿WZRUWKDQ
DGGLWLRQDOFRVW"

3
 +($/7+(&2120,&6*(1(5$/,668(6

$ QXPEHU RI (XURSHDQ FRXQWULHV ORQJ KDYH UHTXHVWHG FRVWHIIHFWLYHQHVV DVVHVVPHQWV DV DQ DLG
LQ GHFLGLQJ DERXW WKH UHLPEXUVHPHQW VWDWXV RU SULFH RI D QHZ WHFKQRORJ\ 'HPDQG LV JURZLQJ IRU
FRPSDUDWLYHWULDOVWKDWFDQEHWWHUGH¿QHWKHLQFUHPHQWDOEHQH¿WRIDQHZWUHDWPHQW&RVWHIIHFWLYHQHVV
DQGHYHQFRPSDUDWLYHDQDO\VHVKRZHYHUDUHEDVHGRQPRGHOVFUHDWHGEHIRUHWKHSURGXFWUHDFKHVWKH
PDUNHW8QWLODSURGXFWKDVEHHQXVHGLQURXWLQHFOLQLFDOSUDFWLFHFRQVLGHUDEOHXQFHUWDLQW\UHPDLQV
DERXW ERWK FOLQLFDO RXWFRPH DQG UHVRXUFH XVH $V D UHVXOW DXWKRULWLHV LQFUHDVLQJO\ DUH UHTXHVWLQJ
DGGLWLRQDOHYDOXDWLRQVXVLQJH[SHULHQFHIURPDFWXDOFOLQLFDOSUDFWLFH,QVRPHFDVHVWKHUHVXOWVFDQ
OHDGWRDUHQHJRWLDWLRQRIWKHSULFHDQGDOVRPD\EHXVHGWRVKDSHFOLQLFDOSUDFWLFH

7KH5ROHRI+HDOWK(FRQRPLF(YDOXDWLRQ6WXGLHVLQ0DUNHW$FFHVV
$Q HFRQRPLF HYDOXDWLRQ LV D WRRO IRU DVVHVVLQJ WKH EHQH¿WV DQG FRVWV RI FRPSHWLQJ XVHV RI VFDUFH
UHVRXUFHV,WSURYLGHVGDWDLQDVWUXFWXUHGIRUPDWWKDWLVFRPSDUDEOHDFURVVGLVHDVHVEXWGRHVQRW
LQLWVHOIRIIHUDGHFLVLRQ6LQFHYDOXHIRUPRQH\LVQRZDFRUHFRQFHUQDQDO\VHVRIWKHFRQVHTXHQFHV
RIWKHXVHRIQHZDQGH[LVWLQJWKHUDSLHVLQWHUPVRIERWKEHQH¿WVDQGFRVWVKDYHEHFRPHHVVHQWLDO
WRGHFLVLRQVDERXWUHVRXUFHDOORFDWLRQ&RVWHIIHFWLYHQHVVKDVEHFRPHDQLPSRUWDQWFULWHULRQQRWRQO\
IRU GHFLGLQJ ZKLFK WKHUDSLHV RXJKW WR EH IXQGHG RU UHLPEXUVHG EXW DOVR IRU LGHQWLI\LQJ WKH SDWLHQW
populations that should have access.

)LJXUH'H¿QLWLRQDQGIRUPVRIHFRQRPLFHYDOXDWLRQ
'H¿QLWLRQRIHFRQRPLFHYDOXDWLRQ$FRPSDUDWLYHDQDO\VLVRIWZRRUPRUHRSWLRQVLQWHUPVRIWKHLUFRVWV
DQGFRQVHTXHQFHV

7\SHVRIHFRQRPLFHYDOXDWLRQ

&RVWPLQLPLVDWLRQDQDO\VLV&0$ &RPSDULVRQRIFRVWVRIDOWHUQDWLYHVWKDWKDYHWKH

same health outcome

Allows comparison within a clinical indication

&RVWHIIHFWLYHQHVVDQDO\VLV&($ &RPSDULVRQRIFRVWVDQGGLVHDVHVSHFL¿FKHDOWKRXWFRPHV

HJOLIH\HDUVVDYHGSDWLHQWVFXUHGHYHQWVDYRLGHG

Allows comparison within a clinical indication

&RVWXWLOLW\DQDO\VLV&8$ &RPSDULVRQRIFRVWVDQGJHQHULFKHDOWKRXWFRPHV

HJTXDOLW\DGMXVWHGOLIH\HDUV

Allows comparison across clinical indications

&RVWEHQH¿WDQDO\VLV&%$ &RPSDULVRQRIFRVWVDQGKHDOWKRXWFRPHVYDOXHGLQPRQHWDU\WHUPV

HJZLOOLQJQHVVWRSD\

$OORZVFRPSDULVRQWRRWKHUVHFWRUVRIWKHHFRQRP\

0DQ\FRXQWULHVKDYHRI¿FLDORUTXDVLRI¿FLDOVSHFLDOLVHGJURXSVWKDWDVVHVVWKHYDOXHRIERWKFXUUHQW
and new health care technologies. These may be independent reimbursement agencies or specialised
+7$DJHQFLHV(FRQRPLFHYDOXDWLRQVDUHDQLQWHJUDOSDUWRIWKHLUDVVHVVPHQWV

$QHFRQRPLFHYDOXDWLRQSURYLGHVDFRPSDUDWLYHDQDO\VLVRIDOWHUQDWLYHFRXUVHVRIDFWLRQLQWHUPVRI
FRVWV DQG FRQVHTXHQFHV VHH )LJXUH  7KLV HQWDLOV FRPSDULQJ DOWHUQDWLYH WUHDWPHQW VWUDWHJLHV
RYHUWKHHQWLUHFRXUVHRIDGLVHDVHRUGH¿QHGGLVHDVHHSLVRGHLQRUGHUWRLGHQWLI\WKHEHVWRSWLRQ
IRUVSHFL¿FSDWLHQWJURXSVJLYHQH[SHFWHGFRVWV6XFKHYDOXDWLRQVXVHDJJUHJDWHPHDVXUHPHQWVDQG
SURYLGHLQIRUPDWLRQIRUJURXSVRISDWLHQWVUDWKHUWKDQLQGLYLGXDOSDWLHQWV$OOHYDOXDWLRQVXVHVLPLODU
WHFKQLTXHV WR HVWLPDWH FRVW DOWKRXJK GLIIHUHQW WHFKQLTXHV DUH XVHG IRU PHDVXULQJ FRQVHTXHQFHV
depending on the disease or the desired result.

:KHQ WZR LQWHUYHQWLRQV KDYH WKH VDPH RXWFRPH WKH OHVV FRVWO\ RQH GRPLQDWHV DQG LV SUHIHUUHG
Interest is greater in products that improve outcomes compared to existing treatments that are only
HTXLYDOHQWLQRXWFRPH%XWPRUHHI¿FDFLRXVWHFKQRORJLHVJHQHUDOO\FRPHDWDKLJKHUFRVW7KXVDQ

4
 +($/7+(&2120,&6*(1(5$/,668(6

LQFUHPHQWDOFRVWHIIHFWLYHQHVVUDWLR,&(5LHWKHH[WUDLQYHVWPHQWUHTXLUHGIRUWKHDGGLWLRQDOKHDOWK

EHQH¿WLVFRPSXWHG7KHPRUHFRVWO\LQWHUYHQWLRQZLOOEHDGRSWHGLIWKHLQFUHPHQWDOFRVWSHUXQLWRI
KHDOWKHIIHFWLVOHVVWKDQWKHSXUFKDVHU¶VZLOOLQJQHVVWRSD\IRUVXFKDKHDOWKJDLQ

%R['H¿QLWLRQRIDQ,&(5

>&RVW%±&RVW$@   'LIIHUHQFHLQ&RVW

___________________ or _________________

>(IIHFW%±(IIHFW$@  'LIIHUHQFHLQ(IIHFW

ZKHUH%LVPRUHHIIHFWLYHDQGPRUHH[SHQVLYHWKDQ$

LI%LVPRUHHIIHFWLYHDQGOHVVH[SHQVLYHWKDQ$%GRPLQDWHV$DQGWKH,&(5LVQRWFDOFXODWHG

+HDOWKUHODWHGFRVWVPD\EHLQFXUUHGLQDUDQJHRIVRFLDOVSKHUHVPDNLQJLWLPSRUWDQWWRLQFOXGHDOO
FRVWVIRUDUHOHYDQWWLPHSHULRGHYHQLIWKH\IDOOXQGHUGLIIHUHQWEXGJHWV)RULQVWDQFHDQHZWUHDWPHQW
PD\LQFUHDVHWKHSKDUPDFHXWLFDOEXGJHWEXWRYHUWLPHSURGXFHHQRXJKVDYLQJVLQRWKHUSDUWVRIWKH
V\VWHPWRSDUWO\RUIXOO\RIIVHWWKLVLQFUHDVHVXFKDVORZHUKRVSLWDOLVDWLRQFRVWVRUIHZHUPRQLWRULQJ
UHTXLUHPHQWV6DYLQJVDOVRPD\RFFXULQRWKHUVHFWRUVRIWKHHFRQRP\IRUH[DPSOHZKHQVLFNQHVV
DEVHQFHVHDUO\UHWLUHPHQWGXHWRGLVHDVHRUSUHPDWXUHGHDWKVDUHDYRLGHG)RUHI¿FLHQWUHVRXUFH
DOORFDWLRQGHFLVLRQVVKRXOGFRQVLGHUWKHIXOOLPSDFWRIWKHUDSLHVUHJDUGOHVVRIZKHUHHIIHFWVRFFXU
(FRQRPLFHYDOXDWLRQVWKHQPXVWVWDUWIURPDVRFLHWDOSHUVSHFWLYHWRFDSWXUHDOOSRWHQWLDOEHQH¿WV

$GRSWLQJ D VRFLHWDO SHUVSHFWLYH WR DVVHVVLQJ WKH YDOXH RI WUHDWPHQWV PDWWHUV DQG PDNHV VHQVH
-|QVVRQ  -RKDQQHVVRQ HW DO  5HJXODWRU\ DXWKRULWLHV WDNH D VRFLHWDO SHUVSHFWLYH LQ
OLFHQVLQJDGUXJZHLJKLQJULVNVDJDLQVWZLGHUEHQH¿WV(FRQRPLFDQDO\VHVVLPLODUO\QHHGWRLQFOXGH
ERWK FRVWV DQG EHQH¿WV WR VRFLHW\ RYHUDOO 7KLV FDQ KHOS GHFLVLRQ PDNHUV DYRLG DQ RYHUO\ QDUURZ
EXGJHWVSHFL¿FSHUVSHFWLYHZKLFKPD\PLVVWKHLPSRUWDQWEHQH¿WVDFFUXHGRXWVLGHWKDWEXGJHWDQG
produce suboptimal decisions about resource allocation. Narrow decisions may inappropriately restrict
DFFHVV E\ QRW IXQGLQJ WKH WUHDWPHQW DW DOO RU E\ LQDSSURSULDWHO\ OLPLWLQJ LW WR RQO\ VRPH JURXSV
RI SDWLHQWV ,Q VXFK FDVHV WKH SD\HU PD\ DFKLHYH WKH REMHFWLYH RI FRQWUROOLQJ WKH EXGJHW VWDWLF
HI¿FLHQF\EXWWKHJUHDWHUEHQH¿WWRVRFLHW\SDUWLFXODUSDWLHQWVZLOOEHPLVVHGG\QDPLFHI¿FLHQF\

'HVSLWH WKH UDWKHU REYLRXV SRWHQWLDO EHQH¿W RI XVLQJ KHDOWK HFRQRPLF HYDOXDWLRQV GHFLVLRQ PDNHUV
DFURVV(XURSHYDU\LQKRZDQGKRZPXFKWKH\DUHXVHG7KHUHPLWVRIGHFLVLRQPDNLQJRUJDQLVDWLRQV
DOVRGLIIHU+7$DJHQFLHVDUHJHQHUDOO\FRQFHUQHGZLWKZKHWKHURUQRWWRUHFRPPHQGWUHDWPHQWVEXW
ODFNWKHSRZHUWRGHFLGHRQDFFHVVDQGSULFHVRPHUHLPEXUVHPHQWDJHQFLHVFDQRQO\DFFHSWRUUHIXVH
WRIXQGDWUHDWPHQWDWWKHSURSRVHGSULFHZKLOHRWKHUVKDYHWKHSRZHUWRQHJRWLDWHSULFH)LJXUH

,Q UHFHQW \HDUV +7$ DJHQFLHV KDYH EHFRPH LQFUHDVLQJO\ LQYROYHG LQ GHFLVLRQV DERXW HDUO\ PDUNHW
DFFHVV EOXUULQJ WKH GLVWLQFWLRQ EHWZHHQ WKHLU DFWLYLWLHV DQG WKRVH RI WUDGLWLRQDO UHLPEXUVHPHQW
DVVHVVPHQWV )RU H[DPSOH WKH 1DWLRQDO ,QVWLWXWH IRU +HDOWK DQG &DUH ([FHOOHQFH 1,&( ZLWKLQ
WKH 1DWLRQDO +HDOWK 6HUYLFH 1+6 LQ WKH 8. DVVHVVHV VHOHFWHG QHZ WUHDWPHQWV HDUO\ RQ DQG LWV
UHFRPPHQGDWLRQVDUHELQGLQJ'HFLVLRQVE\WKH6FRWWLVK0HGLFLQHV&RQVRUWLXPDQ+7$ERG\ZLWKLQ
WKH 6FRWWLVK 1+6 DUH IXOO\ ELQGLQJ ,Q )UDQFH WKH +DXWH $XWRULWp GH 6DQWp +$6 LQFOXGHV ERGLHV
WKDWDVVHVVWKHDEVROXWHDQGUHODWLYHEHQH¿WRIDQHZWHFKQRORJ\DQGLWVUHLPEXUVHPHQWVWDWXVDQG
WKRVHWKDWSHUIRUPIXOODVVHVVPHQWVRIWHFKQRORJLHVDIWHUWKH\KDYHHQWHUHGWKHPDUNHW,Q*HUPDQ\
WKH ,QVWLWXWH IRU 4XDOLW\ DQG (I¿FLHQF\ LQ +HDOWK &DUH ,4:L* DVVHVVHV WKH HIIHFWLYHQHVV²DQG LI
UHTXHVWHGFRVWHIIHFWLYHQHVV²RIQHZWUHDWPHQWVRQH\HDUDIWHUWKHLULQWURGXFWLRQ&OHDUO\WKHQWKH
WLPLQJDQGLPSDFWRIFRVWHIIHFWLYHQHVVVWXGLHVYDULHVDFURVVFRXQWULHVDQGRUJDQLVDWLRQV

*XLGHOLQHVIRUSHUIRUPLQJHFRQRPLFHYDOXDWLRQVKDYHEHHQSURGXFHGLQPDQ\FRXQWULHV7KHVHIDOOLQWR
two categories.

5
 +($/7+(&2120,&6*(1(5$/,668(6

5HLPEXUVHPHQWJXLGHOLQHVLHJXLGHOLQHVLVVXHGE\DXWKRULWLHVWKDWPDNHWKHVXEPLVVLRQRI
HFRQRPLFHYDOXDWLRQVPDQGDWRU\IRUOLVWLQJDQHZSURGXFWRQWKHUHLPEXUVHPHQWIRUPXODU\
DQGWKDWGH¿QHWKHIRUPDWRIVXFKVXEPLVVLRQV

0HWKRGRORJLFDOJXLGHOLQHVLHJXLGHOLQHVSURSRVHGE\UHVHDUFKHUVRUJURXSVRIUHVHDUFKHUV
ZLWK WKH DLP RI LPSURYLQJ WKH WHFKQLTXHV DQG PHWKRGV XVHG DQG PDNLQJ VWXGLHV PRUH
transparent

)LJXUH%RGLHVLQYROYHGLQGHWHUPLQLQJPDUNHWDFFHVV

 5HJXODWRU\DJHQFLHV 5HLPEXUVHPHQWDJHQFLHV +7$DJHQFLHV

5ROH   0DUNHWDXWKRULVDWLRQ
 &RYHUDJHGHFLVLRQZLWKLQD Provide best evidence
VXEVHTXHQWUHYLHZRI health care system, given WRLQIRUPFRYHUDJH
EHQH¿WULVNSUR¿OH resource constraints GHFLVLRQVHJFOLQLFDO
LIZDUUDQWHG SUDFWLFHJXLGHOLQHV

(YLGHQFH $WODXQFKVDIHW\DQG $WODXQFKUHODWLYHHI¿FDF\ At launch:

XVHG HI¿FDF\SRWHQWLDOO\UHOD- HIIHFWLYHQHVVDQGEXGJHW seldom involved
WLYHHI¿FDF\GDWDIURP
randomised clinical trials
Post launch:
VDIHW\IROORZXS
LPSDFWIRUPDOFRVW
HIIHFWLYHQHVVDQDO\VHV
in most countries
Post launch: relative
HIIHFWLYHQHVVDQG
Post launch: relative
HI¿FDF\HIIHFWLYHQHVV
FRVWHIIHFWLYHQHVV FRVWHIIHFWLYHQHVV

3RZHU 'HFLVLRQ 'HFLVLRQZLWKZLWKRXW 5HFRPPHQGDWLRQ

SULFHQHJRWLDWLRQ

7KH¿UVWFRXQWU\WRPDNHVXEPLVVLRQRIHFRQRPLFVWXGLHVDQRI¿FLDOUHTXLUHPHQWIRUOLVWLQJPHGLFLQHV
RQWKHQDWLRQDOGUXJIRUPXODU\IRUUHLPEXUVHPHQWZDV$XVWUDOLDLQ6LQFHWKHQWKHJXLGHOLQHV
IRUVXEPLVVLRQVWR$XVWUDOLD¶V3KDUPDFHXWLFDO%HQH¿WV$GYLVRU\&RPPLWWHH3%$&KDYHEHHQXSGDWHG
VHYHUDOWLPHVWRLQFRUSRUDWHH[SHULHQFHJDLQHG3%$&

7KHVHFRQGFRXQWU\WRUHTXLUHHFRQRPLFVWXGLHVZDV&DQDGDEDVHGRQDQLQLWLDWLYHLQWKHSURYLQFH
RI2QWDULR'HWDLOHGPHWKRGRORJLFDOJXLGHOLQHVZHUHGHYHORSHGLQFROODERUDWLRQZLWKDOOVWDNHKROGHUV
JRYHUQPHQW LQVXUDQFH FRPSDQLHV SURYLGHUV¶ DVVRFLDWLRQV KRVSLWDOV SKDUPDFLVWV SK\VLFLDQV
DFDGHPLDDQGWKHSKDUPDFHXWLFDOLQGXVWU\5HYLVHGHGLWLRQVZHUHSXEOLVKHGLQDQGZLWK
addenda in 2009 that covered indirect treatment comparisons and evaluations in oncology. The
&DQDGLDQ GRFXPHQW LV ZLGHO\ FRQVLGHUHG DXWKRULWDWLYH LQ WHUPV RI PHWKRGRORJLFDO VWDQGDUGV DQG
PRVWRIWKHJXLGHOLQHVSXEOLVKHGVXEVHTXHQWO\E\RWKHUDJHQFLHVKDYHUHOLHGKHDYLO\RQWKH&DQDGLDQ
JXLGHOLQHV&$'7+DQG

,QLWLDOO\(XURSHDQFRXQWULHVWRRNDVRPHZKDWGLIIHUHQWDSSURDFK:KLOHJXLGHOLQHVDVDQH[SUHVVLRQRI
PHWKRGRORJLFDOVWDQGDUGVZHUHHODERUDWHGDQGSXEOLVKHGLQPRVWFRXQWULHVWKH\ZHUHQRWDW¿UVWWLHG
WRUHLPEXUVHPHQWGHFLVLRQV1RZKRZHYHUWKHPDMRULW\RIFRXQWULHVKDYHPDGHHFRQRPLFHYDOXDWLRQV
PDQGDWRU\IRUUHLPEXUVHPHQWGHFLVLRQVDQGUHTXLUHVWXGLHVWRIROORZRI¿FLDOJXLGHOLQHVSURGXFHGE\
WKHUHLPEXUVHPHQWDXWKRULWLHV6HH)LJXUHIRUDQRQH[KDXVWLYHOLVWRIJXLGHOLQHV'LIIHUHQFHV
among the guidelines are limited, with the most important being the perspective that submissions
DUHH[SHFWHGWRDGRSW2WKHUGLIIHUHQFHVUHODWHWRGLVFRXQWUDWHWLPHKRUL]RQDQGOHYHORIGHWDLOLQ
IRUHFDVWLQJXVHRIDQHZSURGXFWLHWKHDQWLFLSDWHGEXGJHWLPSDFW$VPDQ\RIWKHFRXQWULHVWKDW
KDYHPDGHWKHVHVWXGLHVPDQGDWRU\DUHUDWKHUVPDOOWKH\PLQLPL]HDGGLWLRQDOHIIRUWE\DFFHSWLQJWKH
UHVXOWVRIVWXGLHVIURPRWKHUFRXQWULHVZLWKDSSURSULDWHDGDSWDWLRQWRORFDOQHHGV

,QWKH86WKH'HSDUWPHQWRI+HDOWKDQG+XPDQ6HUYLFHVFRPPLVVLRQHGDSDQHORIDFDGHPLFH[SHUWV
WKH ³:DVKLQJWRQ 3DQHO´ WR HODERUDWH D VHW RI JXLGHOLQHV IRU JRRG SUDFWLFH 7KH HIIRUW SURGXFHG D
ZLGHO\TXRWHGERRN*ROGHWDOWKDWKDVVSDUNHGLQWHQVHVFLHQWL¿FGLVFXVVLRQDLPHGDWIXUWKHU
GHYHORSPHQWRIWKHPHWKRGV6LQFHWKHQWKH$FDGHP\RI0DQDJHG&DUH3KDUPDF\KDVSXEOLVKHGD
PRUHVSHFL¿FVHWRIJXLGHOLQHVIRUVXEPLVVLRQVAMCP guidance for submission of clinical and economic

6
 +($/7+(&2120,&6*(1(5$/,668(6

)LJXUH8VHRIHFRQRPLFHYDOXDWLRQLQYDULRXVFRXQWULHV

)RUPDO 5HVHDUFK
  *XLGHOLQHV *XLGHOLQHV
  <HDURIVW <HDURIVW
&RXQWU\ 8VHRIHFRQRPLFHYDOXDWLRQ publication publication

$XVWUDOLD 5HTXLUHGIRUDOOQHZGUXJV  1$

$XVWULD 5HTXLUHGIRUDOORXWSDWLHQWGUXJVZLWKIRFXVRQ 1$ 

comparison budget impact and price

%HOJLXP 5HTXLUHGIRUDOORXWSDWLHQWGUXJVZLWKIRFXVRQ 1$ 

 DGGHGEHQH¿WDVVHVVPHQW

&DQDGD 5HTXLUHGDWQDWLRQDODQGSURYLQFLDOOHYHO  1$

'HQPDUN Voluntary submission NA 1997

)LQODQG 5HTXLUHGIRUDOORXWSDWLHQWGUXJV  1$

)UDQFH 5HLPEXUVHPHQWRQO\EDVHGRQDGGHGEHQH¿W  

re-assessment by HTA agency

*HUPDQ\ 8SRQUHTXHVWRQH\HDUDIWHUODXQFK  

+XQJDU\ 5HTXLUHGIRUDOOGUXJV  1$

,WDO\ $XWKRULW\WRUHTXHVWDWQDWLRQDODQGUHJLRQDOOHYHO 1$ 

1HWKHUODQGV 5HTXLUHGIRUDOOQHZGUXJVRXWVLGHH[LVWLQJFOXVWHUV  1$

1HZ=HDODQG 5HTXLUHGIRUDOOQHZGUXJV  1$

1RUZD\ 5HTXLUHGIRUDOOSUHVFULSWLRQGUXJV  1$

3RODQG 5HTXLUHGIRULQQRYDWLYHGUXJV  1$

3RUWXJDO 5HTXLUHGIRUDOOQHZRXWSDWLHQWDQGLQSDWLHQWGUXJV  1$

6SDLQ 1RWUHTXLUHGDWQDWLRQDOOHYHOFDQEHXVHGDW  

regional level

6ZHGHQ 5HTXLUHGIRUDOOQHZGUXJV  1$

8.(QJODQG 6XEPLVVLRQVUHTXHVWHGRQGH¿QHGGUXJV  1$

:DOHV DQGGHYLFHVHLWKHUIRUUHYLHZRIFODVVRUIRU
single technology appraisal

8.6FRWODQG 5HTXLUHGIRUDOOQHZGUXJVDQGGHYLFHV  1$

86$ ,QFRQVLVWHQWO\XVHGIRUOLVWLQJ 1$ 

HYDOXDWLRQGDWDWRVXSSRUWIRUPXODU\OLVWLQJLQ86KHDOWKSODQVDQGSKDUPDF\EHQH¿WVPDQDJHPHQW
organisations 6XOOLYDQHWDO

,QDGGLWLRQWRWKHGRFXPHQWVDQGJXLGHOLQHVSURGXFHGE\LQGLYLGXDOFRXQWULHVDJURXSRIDFDGHPLF
researchers published a report on researcher independence in 1995 that attempts to deal with problems
RIELDVLQHFRQRPLFHYDOXDWLRQ7DVN)RUFH7KHUHSRUWVXJJHVWVWKDWHYDOXDWLRQVRXJKWRQO\WR
EHSHUIRUPHGE\LQGHSHQGHQWUHVHDUFKHUVZLWKQRGLUHFW¿QDQFLDOOLQNWRWKHVSRQVRURULIDVWXG\LV
VSRQVRUHGUHVHDUFKHUVVKRXOGKDYHFRPSOHWHIUHHGRPWRSXEOLVKDQ\DQGDOOUHVXOWV7KLVLVEDVHGLQ
SDUWRQFRQFHUQVDERXWLQDSSURSULDWHPRGL¿FDWLRQDWDODWHUVWDJHRIHOHPHQWVVXFKDVHIIHFWLYHQHVV
PHDVXUHVDQGDQDO\WLFDOPHWKRGV8QOLNHSURWRFROVIRUFOLQLFDOWULDOVWKRVHIRUWKHHFRQRPLFHYDOXDWLRQ
RIQHZGUXJVDUHQRWDOZD\VGH¿QHGLQGHWDLODWWKHRXWVHW+RZHYHUWKHVROXWLRQWRSRWHQWLDOHWKLFDO
problems such as this surely must lie in adherence to good practices by all participants in this evolving
¿HOGUDWKHUWKDQLQFRQWUDFWXDODUUDQJHPHQWV


 +($/7+(&2120,&6*(1(5$/,668(6

6LPLODUO\ DOOHJDWLRQV WKDW RQO\ VWXGLHV ZLWK SRVLWLYH UHVXOWV DUH SXEOLVKHG LQGLFDWH D IXQGDPHQWDO
PLVXQGHUVWDQGLQJ RI WKH SXUSRVH RI HFRQRPLF HYDOXDWLRQ )LUVW DQG IRUHPRVW HFRQRPLF H  YDOXDWLRQ
VWXGLHVDUHDWRROWRVXSSRUWGHFLVLRQVDERXWUHVRXUFHDOORFDWLRQ7KHSULPDU\SXUSRVHRIVXFKVWXGLHV
WKHQLVQRWWRDFKLHYHSXEOLFDWLRQEXWWRLQIRUPGHFLVLRQPDNLQJ%\QDWXUHWKH\DUHQRWK\SRWKHVLV
WHVWLQJ LQ WKH ZD\ WKDW FOLQLFDO WULDOV DUH EXW LQVWHDG VHHN VFHQDULRV ZKHUH WKH SURGXFW XQGHU
HYDOXDWLRQFDQEHH[SHFWHGWREHFRVWHIIHFWLYH7KHVFHQDULRVPD\LQYROYHVSHFL¿FSDWLHQWSRSXODWLRQV
VXEJURXSVVSHFL¿FDGPLQLVWUDWLYHFRQGLWLRQVVSHFL¿FSRVLWLRQLQJ¿UVWOLQHRUVHFRQGOLQHWKHUDS\
ODVW UHVRUW DQG VR RQ²DOO YDULDEOHV WKDW DUH LQIRUPHG E\ WKH FOLQLFDO WULDO UHVXOWV DQG KHQFH RIWHQ
FDQQRWEHVSHFL¿HGLQDJHQHUDOVHWRIJXLGHOLQHVEHIRUHKDQG7KHJRDORISD\HUVLVWRPDNHWUHDWPHQWV
DYDLODEOHLQDQHI¿FLHQWZD\LHWRWKRVHSDWLHQWVPRVWLQQHHGDQGLQWKRVHVHWWLQJVZKHUHWKH\DUH
FRVW HIIHFWLYH ³1HJDWLYH´ UHVXOWV LH KLJK ,&(5V DUH WKXV RI QR LQWHUHVW H[FHSW IRU UHMHFWLQJ WKDW
SDUWLFXODU VFHQDULR 7KH RQO\ ZD\ WR HQVXUH ERWK FUHGLELOLW\ RI WKH FODLPV RI YDOXH IRU PRQH\ DQG
XVHIXOQHVVRIWKHVWXGLHVWRGHFLVLRQPDNHUVLVWRXVHVRXQGPHWKRGRORJ\DQGUHOHYDQWGDWDDQGWR
report results in a complete and transparent manner.

Among those countries where economic analysis must be considered prior to deciding on reimbursement
IRU QHZ SURGXFWV HFRQRPLF VXEPLVVLRQV DOVR DUH UHTXLUHG ZKHQ DSSURYDO LV VRXJKW IRU D QHZ
LQGLFDWLRQ IRU DQ H[LVWLQJ WUHDWPHQW %XW DV LV DSSDUHQW IURP )LJXUH  FRQVLGHUDEOH GLIIHUHQFHV
H[LVWLQWKHH[WHQWWRZKLFKHFRQRPLFDQDO\VLVLVXVHG6ZHGHQDQG)LQODQGLQIRUPDOO\XVHGHFRQRPLF
HYDOXDWLRQVLQGHFLVLRQPDNLQJHYHQSULRUWRWKHV\VWHPDWLFDVVHVVPHQWRIDOOQHZWHFKQRORJLHV,Q7KH
1HWKHUODQGVDQHFRQRPLFFULWHULRQLVDSSOLHGWRUHLPEXUVHPHQWGHFLVLRQVRQO\IRUGUXJVWKDWFDQQRW
EHLQFOXGHGLQDQH[LVWLQJWKHUDSHXWLFFOXVWHUXQGHUWKHUHIHUHQFHSULFLQJVFKHPH,Q1RUZD\DOOQHZ
SURGXFWVIRUJHQHUDOSUHVFULSWLRQVFKHGXOHUHTXLUHDQHFRQRPLFVXEPLVVLRQZKLOHLQ3RUWXJDOERWK
RXWSDWLHQWDQGKRVSLWDOGUXJVDUHVXEMHFWWRHFRQRPLFHYDOXDWLRQ%HOJLXPDQG$XVWULDERWKUHTXLUH
HFRQRPLF HYDOXDWLRQV EXW %HOJLXP DSSHDUV WR KDYH D VWURQJ IRFXV RQ DGGHG EHQH¿W ZKLOH $XVWULD
DSSHDUVWRIRFXVRQSULFHFRPSDULVRQVDQGEXGJHWLPSDFW,Q6FRWODQGIXQGLQJGHFLVLRQVEDVHGRQ
FRVWHIIHFWLYHQHVVDPRQJRWKHUSDUDPHWHUVDUHELQGLQJ

$PRQJWKHODUJHFRXQWULHVLQ:HVWHUQ(XURSHRQO\WKH8.KDVWUXO\IRUPDOLVHGLWVUHTXLUHPHQWV1,&(
ZDVVHWXSLQE\WKH'HSDUWPHQWRI+HDOWKWRDVVHVVQHZDQGH[LVWLQJKHDOWKWHFKQRORJLHVDQG
recommend whether and how these technologies should be used within the NHS in England and Wales.
6LQFHWKHEHJLQQLQJRILQDQHIIRUWWROLPLWUHJLRQDOGLIIHUHQFHVLQDFFHVVLWKDVEHHQREOLJDWRU\
IRUWKH1+6WRIXQGSUHVFULSWLRQVEDVHGRQ1,&(¶VUHFRPPHQGDWLRQV

7KHRUJDQLVDWLRQDQGIXQFWLRQLQJRI1,&(DUHGLIIHUHQWIURPVLPLODUDJHQFLHVLQRWKHUFRXQWULHVLQSDUW
GXHWRWKHORQJWUDGLWLRQRIDFDGHPLFUHVHDUFKLQKHDOWKHFRQRPLFVLQWKH8.FRXSOHGZLWKDGULYHIRU
greater transparency and public discussion.

NICE’s role is to improve outcomes for people using the NHS and other public health and social
care services by:

‡3
 URGXFLQJ HYLGHQFHEDVHG JXLGDQFH DQG DGYLFH IRU KHDOWK SXEOLF KHDOWK DQG VRFLDO FDUH
practitioners;

‡'
 HYHORSLQJTXDOLW\VWDQGDUGVDQGSHUIRUPDQFHPHWULFVIRUWKRVHSURYLGLQJDQGFRPPLVVLRQLQJ
KHDOWKSXEOLFKHDOWKDQGVRFLDOFDUHVHUYLFHV

‡3
 URYLGLQJ D UDQJH RI LQIRUPDWLRQ VHUYLFHV IRU FRPPLVVLRQHUV SUDFWLWLRQHUV DQG PDQDJHUV
across the spectrum of health and social care 1,&(E

$VL]HDEOHFRPSRQHQWRI1,&(¶VZRUNKDVEHHQPDGHXSRIWHFKQRORJ\DSSUDLVDOVZKLFKPD\H[DPLQH
FRPSOHWHLQGLFDWLRQVVLQJOHWHFKQRORJLHVRUHQWLUHFODVVHVRIGUXJV

‡ , VWKHWHFKQRORJ\OLNHO\WRUHVXOWLQDVLJQL¿FDQWKHDOWKEHQH¿WWDNHQDFURVVWKH1+6DVD
ZKROHLIJLYHQWRDOOSDWLHQWVIRUZKRPLWLVLQGLFDWHG"

‡ , VWKHWHFKQRORJ\OLNHO\WRUHVXOWLQDVLJQL¿FDQWLPSDFWRQRWKHUKHDOWKUHODWHG*RYHUQPHQW
SROLFLHVIRUH[DPSOHUHGXFWLRQLQKHDOWKLQHTXDOLWLHV"

8
 +($/7+(&2120,&6*(1(5$/,668(6

‡,VWKHWHFKQRORJ\OLNHO\WRKDYHDVLJQL¿FDQWLPSDFWRQ1+6UHVRXUFHV¿QDQFLDORURWKHULI

JLYHQWRDOOSDWLHQWVIRUZKRPLWLVLQGLFDWHG"

‡,VWKHUHVLJQL¿FDQWLQDSSURSULDWHYDULDWLRQLQWKHXVHRIWKHWHFKQRORJ\DFURVVWKHFRXQWU\"

‡,VWKH,QVWLWXWHOLNHO\WREHDEOHWRDGGYDOXHE\LVVXLQJQDWLRQDOJXLGDQFH")RUH[DPSOHLQWKH
DEVHQFHRIVXFKJXLGDQFHLVWKHUHOLNHO\WREHVLJQL¿FDQWFRQWURYHUV\RYHUWKHLQWHUSUHWDWLRQ
RUVLJQL¿FDQFHRIWKHDYDLODEOHHYLGHQFHRQFOLQLFDODQGFRVWHIIHFWLYHQHVV"1,&(F

:KHQGHYHORSLQJWHFKQRORJ\DSSUDLVDOVJXLGDQFH1,&(FRPPLVVLRQVDQLQGHSHQGHQWDFDGHPLFFHQWUH
to review the existing published evidence on each technology and, in some cases, the evidence contained
LQ WKH PDQXIDFWXUHU¶V VXEPLVVLRQ ,W DOVR PD\ DVN WKH DFDGHPLF JURXS WR SHUIRUP DQ LQGHSHQGHQW
HFRQRPLF HYDOXDWLRQ $ VSHFL¿F JXLGDQFH IRU PDQXIDFWXUHUV KDV EHHQ GHYHORSHG WR H  QVXUH WKDW DOO
VXEPLVVLRQVKDYHWKHVDPHIRUPDWWKH³UHIHUHQFHFDVH´

7KH,PSRUWDQFHRI(FRQRPLF(YDOXDWLRQIRUWKH'HYHORSPHQWRI
1HZ7HFKQRORJLHV

(FRQRPLFHYDOXDWLRQVKDYHEHFRPHDNH\HOHPHQWDQGLQPDQ\FRXQWULHVDPDQGDWRU\UHTXLUHPHQW
in supporting reimbursement submissions. In most pharmaceutical companies, these studies are an
LQWHJUDOSDUWRIUHVHDUFKSRUWIROLRPDQDJHPHQWLQWHQGHGWRGHYHORSHGSURGXFWVIRUWKHPDUNHWWKDW
WKHPDUNHWZDQWV$VLPLODUGHYHORSPHQWLVXQGHUZD\LQWKHPHGLFDOGHYLFHVLQGXVWU\+RZHYHURQFH
reimbursement status has been achieved, little attention has been given to ensuring that products
VWLOO RIIHU YDOXH IRU PRQH\ ZKHQ XVHG LQ DFWXDO FOLQLFDO SUDFWLFH 7KLV LV FKDQJLQJ JUDGXDOO\ DQG DQ
LQFUHDVLQJQXPEHURIFRXQWULHVQRZUHYLHZUHLPEXUVHPHQWGHFLVLRQVDWUHJXODULQWHUYDOVHJ&DQDGD
)UDQFHRUSHULRGLFDOO\HJ6ZHGHQ(QJODQG:DOHV

5HDVVHVVPHQWPD\EHDSDUWLFXODUFKDOOHQJHLQVRPHFDVHV²IRULQVWDQFHLQFKURQLFGLVHDVHVZKHUH
WKHWUHDWPHQWJRDOLVWRGHOD\SURJUHVVLRQWRVHYHUHGLVHDVHVWDWHVZLWKKLJKFRVWVDQGORZTXDOLW\RI
OLIHHJPXOWLSOHVFOHURVLVUKHXPDWRLGDUWKULWLVRULQGLVHDVHDUHDVZKHUHPRVWWUHDWPHQWVDLPWR
SUHYHQWPRUWDOLW\HJKHDUWGLVHDVHFDQFHU)RUVXFKGLVHDVHVLWPD\WDNHDQXPEHURI\HDUVEHIRUH
LWLVSRVVLEOHWRREVHUYHWKHHIIHFWRIDQHZWUHDWPHQWLQWKH³UHDOZRUOG´

(FRQRPLFHYDOXDWLRQVDWODXQFKDUHE\GH¿QLWLRQEDVHGPRVWO\RQUHODWLYHHI¿FDF\REVHUYHGRQWKH
FRQWUROOHGHQYLURQPHQWRIWKHFOLQLFDOWULDO$VVHVVLQJUHODWLYHHIIHFWLYHQHVVDQGKHQFHFRVWHIIHFWLYHQHVV
LQ WKH ³XQFRQWUROOHG´ FOLQLFDO SUDFWLFH HQYLURQPHQW SUHVHQWV TXLWH GLIIHUHQW FKDOOHQJHV +RZHYHU
FRQGLWLRQDOUHLPEXUVHPHQWDSSURYDOVDUHEHFRPLQJFRPPRQW\LQJLQLWLDOUHLPEXUVHPHQWWRVXEVHTXHQW
SURRI RI FRVW HIIHFWLYHQHVV LQ FOLQLFDO SUDFWLFH &RQWUDFWXDO DJUHHPHQWV ZKHUH WKH ¿QDQFLDO ULVN LV
VKDUHGEHWZHHQPDQXIDFWXUHUVDQGWKHKHDOWKFDUHV\VWHPDOVRUHTXLUHHFRQRPLFHYDOXDWLRQEDVHGRQ
FOLQLFDOXVH3HUKDSVWKHJUHDWHVWFKDOOHQJHSUHVHQWHGLVDYDLODELOLW\RIUHOHYDQWFRVWDQGRXWFRPHGDWD
IURPFOLQLFDOSUDFWLFH2EVHUYDWLRQDOIROORZXSFRKRUWVWXGLHVDQGSDWLHQWUHJLVWULHVFDQVXSSO\VXFK
data, provided they are set up do so.

7KH GHPDQG IRU FRPSDUDWLYH GDWD DOUHDG\ H[HUWV D VXEVWDQWLDO LPSDFW RQ WKH FOLQLFDO GHYHORSPHQW
RI QHZ WUHDWPHQWV D VLWXDWLRQ WKDW LV OLNHO\ WR LQWHQVLI\ 0DUNHWLQJ DXWKRULVDWLRQ WUDGLWLRQDOO\ KDV
EHHQEDVHGRQO\RQHI¿FDF\DQGVDIHW\HYLGHQFHIRUWKHSDUWLFXODUSURGXFW7KHFXUUHQWGHPDQGIRU
LPSURYHGUDWKHUWKDQVLPLODURXWFRPHVKRZHYHUUHTXLUHVFRPSDUDWLYHVWXGLHVWKDWFRQVLGHUUHODWLYH
HI¿FDF\7KHFKRLFHRIFRPSDUDWRUFDQKDYHFUXFLDOLPSOLFDWLRQVLQDGGLWLRQWRWKHGLI¿FXOW\RIFKRRVLQJ
D FRPSDUDWRU WKDW LV GHHPHG DQ DSSURSULDWH DOWHUQDWLYH WUHDWPHQW RSWLRQ LQ WKH ODUJHVW Q XPEHU RI
PDUNHWVWKHFKRLFHPDGHDOVRPD\GULYHWKHSRVLWLRQLQJDQGRUWKHSULFHRIWKHQHZSURGXFW

:KLOH UHTXLUHPHQWV IRU FRPSDULVRQV DUH EHLQJ EHWWHU GH¿QHG UHLPEXUVHPHQW DXWKRULWLHV DQG +7$
DJHQFLHV XVXDOO\ DFFHSW LQGLUHFW FRPSDULVRQV EHWZHHQ WUHDWPHQWV 7R JLYH D VLPSOH H[DPSOH LI
WUHDWPHQW$KDVEHHQFRPSDUHGWRWUHDWPHQW%DQGWUHDWPHQW&KDVDOVREHHQFRPSDUHGWRWUHDWPHQW
%LWLVSRVVLEOHWRVWDWLVWLFDOO\HVWLPDWHWKHFRPSDULVRQRI$DQG&7KLVFOHDUO\LVOHVVFHUWDLQWKDQ
GLUHFWFRPSDULVRQSDUWLFXODUO\LIWKHVWXGLHVRI%YHUVXV&ZHUHSHUIRUPHGVRPH\HDUVSULRUWRWKRVH
RI$YHUVXV%RUYLFHYHUVD'HVSLWHWKLVOLPLWDWLRQDJHQFLHVWHQGWRWDNHWKHSUDJPDWLFYLHZWKDWLW
LVEHWWHUWRKDYHDWOHDVWVRPHVXSSRUWLQJHYLGHQFHDYDLODEOHIRUGHFLVLRQPDNLQJ

9
 +($/7+(&2120,&6*(1(5$/,668(6

Integrating comparative research into the development process and combining clinical and economic
REMHFWLYHVSUHVHQWVDQXPEHURIFKDOOHQJHV

‡+RZFDQHI¿FDF\EHWUDQVODWHGLQWRHIIHFWLYHQHVV"

‡:KDWLVDQDSSURSULDWHRXWFRPHPHDVXUH"+RZFDQDSDWLHQW¶VKHDOWKRXWFRPHEHWUDQVIRUPHG
LQWRDTXDQWL¿DEOHPHDVXUHHJTXDOLW\RIOLIHXWLOLW\"

‡:KDWLVDQDSSURSULDWHWLPHIUDPHIRUVXFKHFRQRPLFDQDO\VLVFRPSDUHGWRFOLQLFDOSURRIRI
HI¿FDF\"

‡:KDW LV WKH DSSURSULDWH SURGXFW RU RWKHU LQWHUYHQWLRQ IRU FRPSDULVRQ" $QG KRZ FDQ
FRPSDULVRQVDJDLQVWSODFHEREHLQFRUSRUDWHG"

‡:KHUHDQGKRZFDQUHVRXUFHXVHGDWDEHFROOHFWHG"

6RPHRIWKHVHSRLQWVDUHDGGUHVVHGLQPHWKRGRORJLFDOJXLGHOLQHV0RUHRIWHQKRZHYHUWKHFKRVHQ
DSSURDFK LV JXLGHG E\ IHDVLELOLW\ EDVHG RQ WLPH IUDPH UHVRXUFH FRQVWUDLQWV GDWD DYDLODELOLW\
DQG WKH LQGLFDWLRQ DQG SRVLWLRQLQJ RI WKH QHZ WUHDWPHQW &OLQLFDO WULDOV JHQHUDOO\ DUH UHJDUGHG DV
LQDGHTXDWHYHKLFOHVIRUFROOHFWLQJGDWDRQUHVRXUFHEHFDXVHFRQVXPSWLRQLQDWULDOLVPDQGDWHGDQG
KHDYLO\LQÀXHQFHGE\WKHSURWRFRO$QLOOXVWUDWLRQRIWKHRYHUDOOFRPELQDWLRQRIFOLQLFDODQGHFRQRPLF
GHYHORSPHQWLVSURYLGHGLQ¿JXUHVDQG)LJXUHVKRZVKRZWKHDFFXPXODWLRQRILQIRUPDWLRQ
SURGXFHV HYLGHQFH RI YDOXH IRU PRQH\ )LJXUH  SURYLGHV GHWDLOV DERXW WKH VHTXHQFH DQG SKDVH
WLPLQJRIHFRQRPLFHYDOXDWLRQ

)LJXUH'RFXPHQWLQJYDOXHIRUPRQH\

Clinical
Pivotal
Unmet hypothesis Outcome
clinical
needs testing data
trials
analysis
Decision on Value for
comparator(s) Money
Burden of Simulation of Economic Economic
disease cost- data evaluation
effectiveness collection (model)

7KHHYDOXDWLRQSURFHVVVSDQVWKHHQWLUHGHYHORSPHQWWLPHIRUQHZSURGXFWV,WZLOOEHPRUHVXFFHVVIXO
LISHUIRUPHGZLWKGXHUHJDUGWRWKHDQWLFLSDWHGLQIRUPDWLRQQHHGVRISURYLGHUVDQGSD\HUVDQGLIIXOO\
LQWHJUDWHGLQWRWKHFOLQLFDOGHYHORSPHQWSURFHVV,QWKHHDUOLHUVWDJHVRIGHYHORSPHQWDFWLYLWLHVPRVWO\
LQYROYH EDVLF UHVHDUFK DERXW WKH GLVHDVH LWV HFRQRPLF FRQVHTXHQFHV DQG WKH FRVWV RI W UHDWPHQWV
,QODWHUVWDJHVHFRQRPLFGDWDDUHFROOHFWHGZKLOH3KDVH,,,FOLQLFDOWULDOVDUHWDNLQJSODFH%HFDXVH
HFRQRPLF HYDOXDWLRQV W\SLFDOO\ FRQVLGHU D ZLGHU IUDPH DQG ORQJHU WLPH KRUL]RQ WKDQ FOLQLFDO WULDOV
GDWD IURP GLIIHUHQW VRXUFHV PD\ QHHG WR EH FRPELQHG GDWD RQ WKH GLVHDVH DQG LWV GHYHORSPHQW
HSLGHPLRORJLFDOGDWDGDWDRQSDWLHQWPDQDJHPHQWDQGUHVRXUFHFRQVXPSWLRQHFRQRPLFGDWDDQG
RXWFRPHV GDWD FOLQLFDO WULDOV UHJLVWULHV 0RVW HFRQRPLF HYDOXDWLRQV WKXV DUH PRGHOOLQJ VWXGLHV E\
GHIDXOWDQGVXFKVWXGLHVDUHQRZDFFHSWHGDVWKHUXOHUDWKHUWKDQWKHH[FHSWLRQE\UHLPEXUVHPHQW
authorities and HTA agencies.

&RQGXFWLQJ H[WHQVLYH HFRQRPLF HYDOXDWLRQ DW DOO VWDJHV RI GHYHORSPHQW FDQ EH H[SHQVLYH DQG WKH
NQRZOHGJHJDLQHGOLPLWHGERWKEHFDXVHRIWKHQDWXUHRIFOLQLFDOWULDOVDQGEHFDXVHGDWDDERXWWKHPRVW
HIIHFWLYHXVHRIDSURGXFWDFFXPXODWHVRQO\RYHUWLPHLQDFWXDOXVH6WXGLHVFRQGXFWHGDIWHUODXQFK
FHUWDLQO\ DUH QRW ZLWKRXW FRVW LQFHQWLYHV IRU VXFK H[SHQGLWXUH DUH RQO\ QRZ GHYHORSLQJ $ EDODQFH
PXVWEHVWUXFNEHWZHHQWKHFRVWVDQGWKHEHQH¿WVRISUHSDULQJHFRQRPLFHYDOXDWLRQVWKURXJKRXWD
SURGXFW¶VOLIHF\FOH*HQHUDWLQJHFRQRPLFLQIRUPDWLRQWKDWZLOOQRWEHXVHGRUWKDWFRXOGEHPLVOHDGLQJ
is pointless.

10
 +($/7+(&2120,&6*(1(5$/,668(6

)LJXUH(FRQRPLFHYDOXDWLRQGXULQJDQGDIWHUGHYHORSPHQW

Phase IIIB Marketing

Pre-
clinical Phase I Phase II Phase IIIA Launch

Input into
development

Disease analysis (unmet need)

Burden of disease (quality of life, costs)

Feasibility/Simulation

Data collection (resource use)

Modelling cost-effectiveness

Post-launch studies
(clinical practice)

11